Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 6:8:100240.
doi: 10.1016/j.bjao.2023.100240. eCollection 2023 Dec.

Primary perioperative haemodynamic effects of ß-receptor blockade in patients with catecholamine-secreting tumours

Affiliations

Primary perioperative haemodynamic effects of ß-receptor blockade in patients with catecholamine-secreting tumours

Harald Groeben et al. BJA Open. .

Abstract

Introduction: Guidelines for the treatment of catecholamine-producing tumours strictly recommend starting ß-receptor blocking medication only after α-receptor blockade has been established. This recommendation is supported only by non-surgical case reports. However, in clinical practice ß-receptor blockade is often started before the diagnosis of a phaeochromocytoma is made. As we routinely treat patients with catecholamine-producing tumours without α-receptor blockade, our aim was to evaluate haemodynamic changes in such patients with and without ß-receptor blockade.

Methods: Perioperative blood pressure was assessed prospectively for all patients. The primary outcome was the highest pre-, intra-, and postoperative systolic blood pressure in patients with or without a ß-receptor blockade. Secondary outcomes were the incidence of intraoperative systolic blood pressure peaks >250 mm Hg and hypotensive episodes. Subsequently, a propensity score matching (PSM) analysis was performed.

Results: Out of 584 phaeochromocytoma and paraganglioma resections, 383 operations were performed without α-receptor blockade (including 84 with ß-receptor blockade). Before operation and intraoperatively, patients with ß-receptor blockade presented with higher systolic blood pressure (155 [25] and 207 [62] mm Hg) than patients without ß-receptor blockade (147 [24] and 183 [52] mm Hg; P=0.006 and P=0.001, respectively). Intraoperatively, patients with ß-receptor blockade demonstrated a higher incidence of hypotensive episodes (25% without vs 41% with ß-blockade; P<0.001). After propensity score matching no difference between the groups could be confirmed.

Conclusion: Overall, patients with isolated ß-receptor blockade developed higher blood pressure before operation and intraoperatively. After propensity score matching a difference could no longer be detected. Overall, ß-receptor blockade seems to be more a sign for severe disease than a risk factor for haemodynamic instability.

Keywords: adrenal surgery; adrenergic blockade; arterial hypotension; haemodynamic instability; paraganglioma; perioperative management; phaeochromocytoma; risk factors.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Consort Flow diagram.
Fig 2
Fig 2
Plot of baseline arterial blood pressure in patients with no adrenoceptor blockade or isolated ß-receptor blockade (purple box=no adrenal blockade, blue box=ß-receptor blockade). There are differences over time between the two groups. Post hoc analysis showed higher preoperative and intraoperative maximum systolic blood pressure values for patients with isolated ß-receptor blockade (P<0.001).
Fig 3
Fig 3
Box plot of baseline arterial blood pressure in patients with no adrenoceptor blockade or isolated ß-receptor blockade (purple box=no adrenal blockade, blue box=ß-receptor blockade) after propensity score matching (74 pairs). No differences between the two groups were found.

Similar articles

Cited by

References

    1. Lenders J.W.M., Duh Q.Y., Eisenhofer G., et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:1915–1942. - PubMed
    1. Chen H., Sippel R.S., O’Dorisio S., Vinik A.I., Lloyd R.V., Pacak K. The north American neuroendocrine tumor society consensus guideline for the diagnosis and management of neuroendocrine tumors. Pancreas. 2010;39:775–783. - PMC - PubMed
    1. Hodin R., Lubitz C., Phitayakom R., Stephen A. Diagnosis and management of pheochromocytoma. Curr Probl Surg. 2014;51:151–187. - PubMed
    1. Araujo-Castro M., Pascual-Corrales E., Nattero Chavez L., et al. Protocol for presurgical and anesthetic management of pheochromocytomas and sympathetic paragangliomas: a multidisciplinary approach. J Endocrinol Invest. 2021;44:2545–2555. - PubMed
    1. Kinney M.A.O., Narr B.J., Warner M.A. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth. 2002;16:359–369. - PubMed